Cargando…
Cost-of-illness studies in rare diseases: a scoping review
OBJECTIVE: The aim of this scoping review was to overview the cost-of-illness studies conducted in rare diseases. METHODS: We searched papers published in English in PubMed from January 2007 to December 2018. We selected cost-of-illness studies on rare diseases defined as those with prevalence lower...
Autores principales: | García-Pérez, Lidia, Linertová, Renata, Valcárcel-Nazco, Cristina, Posada, Manuel, Gorostiza, Inigo, Serrano-Aguilar, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045199/ https://www.ncbi.nlm.nih.gov/pubmed/33849613 http://dx.doi.org/10.1186/s13023-021-01815-3 |
Ejemplares similares
-
Health-Related Quality of Life and Perceived Burden of Informal Caregivers of Patients with Rare Diseases in Selected European Countries
por: Valcárcel-Nazco, Cristina, et al.
Publicado: (2022) -
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries
por: Vallejo-Torres, Laura, et al.
Publicado: (2021) -
Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom
por: Angelis, Aris, et al.
Publicado: (2016) -
Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness
por: Linertová, Renata, et al.
Publicado: (2014) -
Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom
por: Angelis, Aris, et al.
Publicado: (2015)